Cargando…
Stem Cell Research Tools in Human Metabolic Disorders: An Overview
Metabolic disorders are very common in the population worldwide and are among the diseases with the highest health utilization and costs per person. Despite the ongoing efforts to develop new treatments, currently, for many of these disorders, there are no approved therapies, resulting in a huge eco...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534517/ https://www.ncbi.nlm.nih.gov/pubmed/34685661 http://dx.doi.org/10.3390/cells10102681 |
_version_ | 1784587571977781248 |
---|---|
author | Ricci, Serena Cacialli, Pietro |
author_facet | Ricci, Serena Cacialli, Pietro |
author_sort | Ricci, Serena |
collection | PubMed |
description | Metabolic disorders are very common in the population worldwide and are among the diseases with the highest health utilization and costs per person. Despite the ongoing efforts to develop new treatments, currently, for many of these disorders, there are no approved therapies, resulting in a huge economic hit and tension for society. In this review, we recapitulate the recent advancements in stem cell (gene) therapy as potential tools for the long-term treatment of both inherited (lysosomal storage diseases) and acquired (diabetes mellitus, obesity) metabolic disorders, focusing on the main promising results observed in human patients and discussing the critical hurdles preventing the definitive jump of this approach from the bench to the clinic. |
format | Online Article Text |
id | pubmed-8534517 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85345172021-10-23 Stem Cell Research Tools in Human Metabolic Disorders: An Overview Ricci, Serena Cacialli, Pietro Cells Review Metabolic disorders are very common in the population worldwide and are among the diseases with the highest health utilization and costs per person. Despite the ongoing efforts to develop new treatments, currently, for many of these disorders, there are no approved therapies, resulting in a huge economic hit and tension for society. In this review, we recapitulate the recent advancements in stem cell (gene) therapy as potential tools for the long-term treatment of both inherited (lysosomal storage diseases) and acquired (diabetes mellitus, obesity) metabolic disorders, focusing on the main promising results observed in human patients and discussing the critical hurdles preventing the definitive jump of this approach from the bench to the clinic. MDPI 2021-10-07 /pmc/articles/PMC8534517/ /pubmed/34685661 http://dx.doi.org/10.3390/cells10102681 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ricci, Serena Cacialli, Pietro Stem Cell Research Tools in Human Metabolic Disorders: An Overview |
title | Stem Cell Research Tools in Human Metabolic Disorders: An Overview |
title_full | Stem Cell Research Tools in Human Metabolic Disorders: An Overview |
title_fullStr | Stem Cell Research Tools in Human Metabolic Disorders: An Overview |
title_full_unstemmed | Stem Cell Research Tools in Human Metabolic Disorders: An Overview |
title_short | Stem Cell Research Tools in Human Metabolic Disorders: An Overview |
title_sort | stem cell research tools in human metabolic disorders: an overview |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534517/ https://www.ncbi.nlm.nih.gov/pubmed/34685661 http://dx.doi.org/10.3390/cells10102681 |
work_keys_str_mv | AT ricciserena stemcellresearchtoolsinhumanmetabolicdisordersanoverview AT caciallipietro stemcellresearchtoolsinhumanmetabolicdisordersanoverview |